A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
Clinical trial NCT03131687 · COMPLETED
Trial details
- NCT number
- NCT03131687
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-24
- Primary completion
- 2018-08-01
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.